Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion type Assertion NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_head.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion description "[Oligonucleotide-microarray analysis of 251 neuroblastoma specimens demonstrated that CADM1 downregulation is associated with unfavourable prognostic markers like disseminated stage 4, age >18 months, MYCN amplification and chromosome 11q alterations (P<0.001 each).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_provenance.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion evidence source_evidence_literature NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_provenance.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion SIO_000772 18084322 NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_provenance.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion wasDerivedFrom befree-20140225 NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_provenance.
- NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_assertion wasGeneratedBy ECO_0000203 NP742180.RA5cw5PvNkIz9dRFwASLFq4N60OJqaztV45sngcG5W_A8130_provenance.